AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29103440 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser irradiation (LLLI) applied at 3-week intervals; energy density of 7.5 J/cm2/point, applied at baseline and then repeated after 3 weeks for 2 more visits.
Number of subjects: 22
Study 29103440 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no laser irradiation)
Number of subjects: 22
Study 25830642 — intervention group
Group type: EXPERIMENTAL
Intervention: Paraspinal anesthetic block with 1% lidocaine without epinephrine
Number of subjects: 0
Study 25830642 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study 23184014 — intervention group
Group type: EXPERIMENTAL
Intervention: ω‐3 fatty acid supplementation (2 g/day)
Number of subjects: 20
Study 23184014 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 21788992 — intervention group
Group type: EXPERIMENTAL
Intervention: Anchoring stent (5F double-pigtail plastic stent)
Number of subjects: 33
Study 19001559 — intervention group
Group type: EXPERIMENTAL
Intervention: Desvenlafaxine (100 mg/d)
Number of subjects: 20
Study 19001559 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine (20 mg/d)
Number of subjects: 20
Study 16440532 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (400 IU/d)
Number of subjects: 63
Study 16440532 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 14676459 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.625 mg CEE and 2.5 mg MPA every other day
Number of subjects: 84
Study 14676459 — intervention group
Group type: COMPARATOR
Intervention: 0.625 mg CEE and 2.5 mg MPA every day
Number of subjects: 84
Study 11035973 — intervention group
Group type: EXPERIMENTAL
Intervention: Boazul cuff (tourniquet)
Number of subjects: 38
Study 11035973 — intervention group
Group type: COMPARATOR
Intervention: Non-tourniquet group
Number of subjects: 38
Study 8783954 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracervical block
Number of subjects: 30
Study 8783954 — intervention group
Group type: COMPARATOR
Intervention: Intravenous cocktail of pethidine and diazepam
Number of subjects: 30
Study 1728807 — intervention group
Group type: EXPERIMENTAL
Intervention: High-potency multivitamin-mineral supplement
Number of subjects: 22
Study 1728807 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 6705484 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injections of propranolol
Number of subjects: 0
Study 6705484 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injections of phentolamine
Number of subjects: 0
Study 6705484 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 0
Study 6705484 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusions of neostigmine
Number of subjects: 0
Study 6705484 — intervention group
Group type: COMPARATOR
Intervention: Normotensive subjects (control group)
Number of subjects: 0
Study 31127413 — intervention group
Group type: EXPERIMENTAL
Intervention: Tube insertion combined with adenoidectomy
Number of subjects: 184
Study 31127413 — intervention group
Group type: COMPARATOR
Intervention: Simple tube insertion
Number of subjects: 184
Study 31127413 — intervention group
Group type: EXPERIMENTAL
Intervention: Tympanic membrane tube for less than 12 months
Number of subjects: 184
Study 31127413 — intervention group
Group type: EXPERIMENTAL
Intervention: Tympanic membrane tube for more than 12 months
Number of subjects: 184
Study 28219477 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous incus
Number of subjects: 20
Study 28219477 — intervention group
Group type: COMPARATOR
Intervention: Titanium partial ossicular replacement prosthesis
Number of subjects: 20
Study 26011427 — intervention group
Group type: EXPERIMENTAL
Intervention: Community level intervention
Number of subjects: 455
Study 26011427 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual level intervention
Number of subjects: 455
Study 26011427 — intervention group
Group type: EXPERIMENTAL
Intervention: Community plus individual intervention
Number of subjects: 455
Study 26011427 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 455
Study 26011427 — intervention group
Group type: COMPARATOR
Intervention: All arms (including control)
Number of subjects: 455
Study 23354414 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (BR) 0.5 l/day for 15 days
Number of subjects: 8
Study 23354414 — intervention group
Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (PL)
Number of subjects: 8
Study 23354414 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (BR)
Number of subjects: 8
Study 20644555 — intervention group
Group type: COMPARATOR
Intervention: 30 mg PI2 in a minidrink
Number of subjects: 24
Study 20644555 — intervention group
Group type: COMPARATOR
Intervention: Control (minidrink without PI2)
Number of subjects: 24
Study 19815144 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved readability and processability form (MIC + SS)
Number of subjects: 60
Study 19815144 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved readability form (MIC)
Number of subjects: 60
Study 19815144 — intervention group
Group type: COMPARATOR
Intervention: AAO informed consent form
Number of subjects: 60
Study 17199056 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic depression treatment program delivered by specialized nurses over 12 months
Number of subjects: 329
Study 17199056 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 329
Study 17199056 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic depression treatment program
Number of subjects: 329
Study 15114435 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg sulpiride
Number of subjects: 36
Study 15114435 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 11978148 — intervention group
Group type: EXPERIMENTAL
Intervention: P. ginseng extract 200 mg
Number of subjects: 30
Study 11978148 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 10400840 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive SPT responses to pets
Number of subjects: 1859
Study 10400840 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive SPT responses to grass
Number of subjects: 1859
Study 10400840 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive SPT responses to mites
Number of subjects: 1859
Study 7782594 — intervention group
Group type: EXPERIMENTAL
Intervention: Mezlocillin (150 mg/kg/12 h)
Number of subjects: 286
Study 1777364 — intervention group
Group type: EXPERIMENTAL
Intervention: Transthoracic electrical bioimpedance (TEB)
Number of subjects: 0
Study 1777364 — intervention group
Group type: COMPARATOR
Intervention: Non-imaging dual beam Doppler ultrasound
Number of subjects: 0
Study 1777364 — intervention group
Group type: EXPERIMENTAL
Intervention: Both TEB and Doppler methods
Number of subjects: 0
Study 6265082 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive induction chemotherapy (high-dose cyclophosphamide, doxorubicin, and VP-16-213)
Number of subjects: 54
Study 6265082 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive induction chemotherapy
Number of subjects: 54
Study 6741672 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 10
Study 6741672 — intervention group
Group type: COMPARATOR
Intervention: Sham-smoking
Number of subjects: 10
Study 31657255 — intervention group
Group type: EXPERIMENTAL
Intervention: RadioEar IP30 insert earphone
Number of subjects: 25
Study 31657255 — intervention group
Group type: EXPERIMENTAL
Intervention: LZeqETSPL approach
Number of subjects: 25
Study 31657255 — intervention group
Group type: COMPARATOR
Intervention: Reference threshold levels of the insert earphone ER-3A
Number of subjects: 25
Study 29462986 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing desks and balance pads (IG) for 11 weeks
Number of subjects: 38
Study 29462986 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing desks and balance pads (IG)
Number of subjects: 38
Study 29462986 — intervention group
Group type: COMPARATOR
Intervention: Control class (CG) received lessons as usual
Number of subjects: 38
Study 27578252 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange juice with 5.5 g of added orange pomace fibre (OPF)
Number of subjects: 0
Study 27578252 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole orange (WO)
Number of subjects: 0
Study 27578252 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange-flavoured beverage with low dose OPF (2.5 g)
Number of subjects: 0
Study 27578252 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange-flavoured beverage with high dose OPF (5.5 g)
Number of subjects: 0
Study 27578252 — intervention group
Group type: COMPARATOR
Intervention: Control (orange-flavoured beverage without fibre)
Number of subjects: 0
Study 24935561 — intervention group
Group type: EXPERIMENTAL
Intervention: Supra-therapeutic dose of drugs (specific drugs not mentioned)
Number of subjects: 0
Study 24935561 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24935561 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin (positive control)
Number of subjects: 0
Study 24935561 — intervention group
Group type: EXPERIMENTAL
Intervention: New model based on change from baseline
Number of subjects: 0
Study 22871351 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalent r-fHBP vaccine (20μg)
Number of subjects: 103
Study 22871351 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalent r-fHBP vaccine (60μg)
Number of subjects: 103
Study 22871351 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalent r-fHBP vaccine (200μg)
Number of subjects: 103
Study 22871351 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 22871351 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalent r-fHBP vaccine
Number of subjects: 103
Study 19548273 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine
Number of subjects: 130
Study 18257185 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with hyperbaric oxygenation
Number of subjects: 60
Study 18257185 — intervention group
Group type: COMPARATOR
Intervention: Simple hyperbaric oxygenation
Number of subjects: 60
Study 15794113 — intervention group
Group type: EXPERIMENTAL
Intervention: Argyle (22 gauge metal needle)
Number of subjects: 20
Study 15794113 — intervention group
Group type: COMPARATOR
Intervention: Insyte (24 gauge plastic cannula with a metal needle)
Number of subjects: 20
Study 14599261 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 0
Study 14599261 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 0
Study 14599261 — intervention group
Group type: EXPERIMENTAL
Intervention: Both nicotine patch and bupropion
Number of subjects: 0
Study 14599261 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10381299 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg (o.a.d. or b.i.d.)
Number of subjects: 365
Study 10381299 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 365
Study 8603644 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive Medline search
Number of subjects: 308
Study 8603644 — intervention group
Group type: COMPARATOR
Intervention: Basic Medline search
Number of subjects: 308
Study 1677551 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical administration of levocabastine (0.5 mg/mL)
Number of subjects: 12
Study 1677551 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical administration of levocabastine (2.0 mg/mL)
Number of subjects: 12
Study 1677551 — intervention group
Group type: COMPARATOR
Intervention: Triprolidine (10 mg)
Number of subjects: 12
Study 6343868 — intervention group
Group type: EXPERIMENTAL
Intervention: tranexamic acid
Number of subjects: 775
Study 6343868 — intervention group
Group type: EXPERIMENTAL
Intervention: cimetidine
Number of subjects: 775
Study 6343868 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 775
Study 30845346 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium nitrate (8 or 24 mmol KNO3)
Number of subjects: 33
Study 30845346 — intervention group
Group type: COMPARATOR
Intervention: Potassium chloride (KCl; placebo)
Number of subjects: 33
Study 29695589 — intervention group
Group type: COMPARATOR
Intervention: low‐dose subcutaneous crenezumab 300 mg every 2 weeks (n = 184)
Number of subjects: 431
Study 29695589 — intervention group
Group type: COMPARATOR
Intervention: high‐dose intravenous crenezumab 15 mg/kg every 4 weeks (n = 247)
Number of subjects: 431
Study 29695589 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 431
Study 27400947 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib 60 mg once per day
Number of subjects: 1028
Study 27400947 — intervention group
Group type: COMPARATOR
Intervention: Prednisone 5 mg twice per day
Number of subjects: 1028
Study 24502769 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonic and Phasic Alertness Training (TAPAT)
Number of subjects: 114
Study 24502769 — intervention group
Group type: COMPARATOR
Intervention: Active control computer games condition
Number of subjects: 114
Study 22102056 — intervention group
Group type: EXPERIMENTAL
Intervention: β-alanine (BA, 2×800 mg tablets, 3× daily; CarnoSyn®; n=13)
Number of subjects: 24
Study 22102056 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL, 2×800 mg maltodextrin tablets, 3× daily; n=11)
Number of subjects: 24
Study 22102056 — intervention group
Group type: EXPERIMENTAL
Intervention: β-alanine (BA)
Number of subjects: 24
Study 20553661 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth CD-ROM intervention plus parent component
Number of subjects: 513
Study 20553661 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth CD-ROM intervention only
Number of subjects: 513
Study 20553661 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 513
Study 18090054 — intervention group
Group type: EXPERIMENTAL
Intervention: Tipranavir/ritonavir
Number of subjects: 0
Study 18090054 — intervention group
Group type: COMPARATOR
Intervention: Lopinavir/ritonavir
Number of subjects: 0
Study 15817604 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg/m² + carboplatin AUC 5 (arm B)
Number of subjects: 81
Study 15817604 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin AUC 5 (arm A)
Number of subjects: 81
Study 12493094 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (nutrition education programmes)
Number of subjects: 926
Study 12493094 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 926
Study 9222866 — intervention group
Group type: EXPERIMENTAL
Intervention: RLP-cholesterol assay
Number of subjects: 0
Study 3181146 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. etomidate (0.3 mg kg‐1)
Number of subjects: 22
Study 3181146 — intervention group
Group type: COMPARATOR
Intervention: thiopentone (4 mg kg‐1)
Number of subjects: 22
Study 4853767 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine sulphate administered orally before and after major surgery
Number of subjects: 0
Study 4853767 — intervention group
Group type: COMPARATOR
Intervention: Untreated group of patients
Number of subjects: 0
Study 31172828 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucine (LEU) supplement
Number of subjects: 22
Study 31172828 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucine-enriched BCAA (LBCAA) supplement
Number of subjects: 22
Study 31172828 — intervention group
Group type: COMPARATOR
Intervention: Standard BCAA supplement
Number of subjects: 22
Study 28727924 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy intervention, assessed at 2 weeks for pain reduction.
Number of subjects: 0
Study 26198363 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS (cathodal to auditory cortex, anode over prefrontal cortex)
Number of subjects: 42
Study 26198363 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 42
Study 23695221 — intervention group
Group type: EXPERIMENTAL
Intervention: Gd-EOB-DTPA-enhanced MRC combined with T2w-MRC
Number of subjects: 99
Study 23695221 — intervention group
Group type: COMPARATOR
Intervention: T2w-MRC
Number of subjects: 99
Study 21858142 — intervention group
Group type: EXPERIMENTAL
Intervention: UpToDate
Number of subjects: 44
Study 21858142 — intervention group
Group type: COMPARATOR
Intervention: PubMed Clinical Queries
Number of subjects: 44
Study 19671126 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-item diabetic foot infection wound score
Number of subjects: 371
Study 19671126 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-item wound score (excluding discharge scores)
Number of subjects: 371
Study 17587710 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum from patients with coronary aneurysms
Number of subjects: 0
Study 17587710 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin plus aspirin
Number of subjects: 0
Study 17587710 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who developed giant aneurysms >8 mm
Number of subjects: 0
Study 17587710 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum activity of stimulating HUVEC proliferation
Number of subjects: 0
Study 17587710 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study 17587710 — intervention group
Group type: COMPARATOR
Intervention: Febrile controls
Number of subjects: 0
Study 15292523 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed total body Th contents and daily urinary excretions in occupational workers
Number of subjects: 5
Study 15292523 — intervention group
Group type: COMPARATOR
Intervention: Theoretically computed Th contents in lungs, skeleton and liver
Number of subjects: 5
Study 15292523 — intervention group
Group type: COMPARATOR
Intervention: Experimentally measured Th contents in lungs, skeleton and liver
Number of subjects: 5
Study 11355096 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite (Tetric, Vivadent)
Number of subjects: 197
Study 11355096 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyacid‐modified resin composite (Dyract, Dentsply)
Number of subjects: 197
Study 11355096 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin‐modified glass ionomer cement (Fuji II LC, GC)
Number of subjects: 197
Study 11355096 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin‐modified glass ionomer cement (Photac‐Fil, Espe)
Number of subjects: 197
Study 9346426 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (Acz) administration
Number of subjects: 125
Study 9346426 — intervention group
Group type: COMPARATOR
Intervention: Physiologic saline (placebo) administration
Number of subjects: 125
Study 8389536 — intervention group
Group type: EXPERIMENTAL
Intervention: Culture preparations of skin specimens from primary EM patients
Number of subjects: 28
Study 8389536 — intervention group
Group type: EXPERIMENTAL
Intervention: Culture preparations of skin specimens from secondary EM patients
Number of subjects: 28
Study 8389536 — intervention group
Group type: EXPERIMENTAL
Intervention: Serologic findings in primary EM patients
Number of subjects: 28
Study 8389536 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical features in secondary EM patients
Number of subjects: 28
Study 8389536 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver enzyme profiles in secondary EM patients
Number of subjects: 28
Study 8389536 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart conditions in secondary EM patients
Number of subjects: 28
Study 8389536 — intervention group
Group type: EXPERIMENTAL
Intervention: Tick bite recall in all patients
Number of subjects: 28
Study 8389536 — intervention group
Group type: EXPERIMENTAL
Intervention: Isomorphic nonresponse in secondary EM
Number of subjects: 28
Study 3518312 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 1.5 mg/kg bw daily, taken in the morning once every three days for 30-45 days
Number of subjects: 0
Study 3518312 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone 30-60 mg daily
Number of subjects: 0
Study 31954837 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise CMD risk assessment followed by individualized treatment
Number of subjects: 0
Study 29444778 — intervention group
Group type: EXPERIMENTAL
Intervention: Shexiang Baoxin Pill (SBP) - 1-2 pills three times daily for at least 6 months
Number of subjects: 440
Study 29444778 — intervention group
Group type: COMPARATOR
Intervention: Placebo (SBP placebo)
Number of subjects: 440
Study 29444778 — intervention group
Group type: EXPERIMENTAL
Intervention: Shexiang Baoxin Pill (SBP)
Number of subjects: 440
Study 26727154 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-use laser device combined with antioxidant facial treatment for 12 weeks followed by 2-week regression period
Number of subjects: 49
Study 26727154 — intervention group
Group type: COMPARATOR
Intervention: Home-use laser device alone for 12 weeks followed by 2-week regression period
Number of subjects: 49
Study 26727154 — intervention group
Group type: COMPARATOR
Intervention: Support materials used on one side for 10 weeks
Number of subjects: 49
Study 25128283 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed participants (prior knowledge of the stolen item)
Number of subjects: 0
Study 25128283 — intervention group
Group type: EXPERIMENTAL
Intervention: Guilty-informed participants
Number of subjects: 0
Study 25128283 — intervention group
Group type: COMPARATOR
Intervention: Guilty-naïve participants
Number of subjects: 0
Study 22045433 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid phase microextraction (SPME)
Number of subjects: 10
Study 22045433 — intervention group
Group type: COMPARATOR
Intervention: Plasma protein precipitation (PPP)
Number of subjects: 10
Study 19385024 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrained eating behaviour
Number of subjects: 33
Study 19385024 — intervention group
Group type: COMPARATOR
Intervention: Unrestrained eating behaviour
Number of subjects: 33
Study 17461308 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative localisation with sestamibi scintigraphy and ultrasonography (group I)
Number of subjects: 100
Study 17461308 — intervention group
Group type: COMPARATOR
Intervention: No preoperative localisation (group II)
Number of subjects: 100
Study 15056389 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention (details not specified)
Number of subjects: 0
Study 15056389 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0